Compound Detail
CHEMBL4211649
TINODASERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4211649 |
| Name | TINODASERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | FWRFPHJSGLYXTD-UHFFFAOYSA-N |
8
Targets
19
Activities
1
Assay Types
19
PK Parameters
20
Publications
5
Known Names
1
Indications
Molecular Properties
408.5
MW (Da)
4.01
ALogP
5
HBA
0
HBD
70.6
PSA (Ų)
0.51
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Neoplasms
Activity Summary
IC50 19 meas. best 8.03
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MAP kinase-interacting serine/threonine-protein kinase 2 CHEMBL4204 | IC50 | 8.03 | 7.374 | 9.4 | 5 |
| MAP kinase-interacting serine/threonine-protein kinase 1 CHEMBL4718 | IC50 | 7.97 | 7.438 | 10.6 | 5 |
| MAP kinase-interacting serine/threonine-protein kinase 1/2 CHEMBL3883293 | IC50 | 6.49 | 6.49 | 321.0 | 1 |
| Eukaryotic translation initiation factor 4E CHEMBL4848 | IC50 | 6.49 | 6.34 | 321.0 | 2 |
| DOHH-2 CHEMBL2366181 | IC50 | 5.79 | 5.305 | 1624.0 | 2 |
| TMD8 CHEMBL4296503 | IC50 | 5.67 | 5.12 | 2138.0 | 2 |
| A549 CHEMBL392 | IC50 | 4.58 | 4.58 | 26300.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.45 | 4.45 | 35500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 5484.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 1761.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 5484.0 | ng.hr.mL-1 | Mus musculus |
| CL | 9.333 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 6074.03 | nM | Mus musculus |
| Cmax | 6074.03 | nM | Mus musculus |
| F | 64.0 | % | Mus musculus |
| F | 64.0 | % | Mus musculus |
| T1/2 | 1.77 | hr | Mus musculus |
| T1/2 | 1.7 | hr | Mus musculus |
| T1/2 | 1.0 | hr | Canis lupus familiaris |
| T1/2 | 1.0 | hr | Rattus norvegicus |
| T1/2 | 0.9333 | hr | Mus musculus |
| T1/2 | 0.8 | hr | Homo sapiens |
| T1/2 | 25.0 | hr | Homo sapiens |
| T1/2 | 1.118 | hr | Homo sapiens |
| T1/2 | 1.392 | hr | Canis lupus familiaris |
| T1/2 | 0.3017 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29683667 | 10.1021/acs.jmedchem.7b01714 | Mus musculus | 14 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | ADMET | 8 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | K562 | 3 |
| 37360400 | 10.1039/d3md00121k | K562 | 3 |
| 38564512 | 10.1021/acs.jmedchem.3c02008 | ADMET | 3 |
| 37360400 | 10.1039/d3md00121k | ADMET | 3 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | No relevant target | 3 |
| 36655132 | 10.1021/acsmedchemlett.2c00442 | Unchecked | 2 |
| 37360400 | 10.1039/d3md00121k | MAP kinase-interacting serine/threonine-protein kinase 2 | 2 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | MAP kinase-interacting serine/threonine-protein kinase 2 | 2 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | Unchecked | 2 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | Cytochrome P450 3A4 | 1 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | MAP kinase-interacting serine/threonine-protein kinase 1/2 | 1 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | MAP kinase-interacting serine/threonine-protein kinase 1 | 1 |
| 30530193 | 10.1016/j.ejmech.2018.11.072 | MAP kinase-interacting serine/threonine-protein kinase 1 | 1 |
| 38564512 | 10.1021/acs.jmedchem.3c02008 | MDA-MB-231 | 1 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | Dual specificity mitogen-activated protein kinase kinase; MEK1/2 | 1 |
| 29683667 | 10.1021/acs.jmedchem.7b01714 | DOHH-2 | 1 |
| 33971490 | 10.1016/j.bmc.2021.116186 | MAP kinase-interacting serine/threonine-protein kinase 1 | 1 |
| 33971490 | 10.1016/j.bmc.2021.116186 | MAP kinase-interacting serine/threonine-protein kinase 2 | 1 |
Data from ChEMBL 36 via Core Engine